ISABEL GUTIERREZ: Open Payments
NPI 1922716778 · NOKOMIS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,125 in 108 payments from 18 companies in 2025. Trend: 2023 $1,150 · 2024 $2,904 · 2025 $2,125
Food & beverage: $2,125
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $514 |
| PFIZER INC. | 15 | $307 |
| AstraZeneca Pharmaceuticals LP | 4 | $187 |
| Amgen Inc. | 18 | $185 |
| Lilly USA, LLC | 10 | $181 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 8 | $161 |
| GlaxoSmithKline, LLC. | 12 | $143 |
| Exact Sciences Corporation | 4 | $110 |
| Novo Nordisk Inc | 5 | $86 |
| Astellas Pharma US Inc | 3 | $70 |
Products named: NURTEC ODT, VRAYLAR, QULIPTA, XIFAXAN, UBRELVY, TRELEGY ELLIPTA, OTEZLA, BREZTRI.
Industry payments across FL — which companies pay providers there.
